Literature DB >> 12080233

A survey of current liver biopsy practice patterns.

Andrew J Muir1, James F Trotter.   

Abstract

GOALS: To survey clinicians regarding current liver biopsy practice patterns.
BACKGROUND: Although the hepatitis C epidemic has increased the proportion of hepatology in general gastroenterology practice, many clinicians express concern regarding the risks of percutaneous liver biopsy. STUDY: A questionnaire about liver biopsy practices was sent to members of the Duke University Digestive Epidemiological Studies Consortium.
RESULTS: The response rate was 112 (71%) of 157. Thirty-three (29.5%) physicians reported that they do not perform liver biopsies. Reasons cited for not performing biopsies included concern about risks (72.7%), low reimbursement (66.7%), and logistical issues with space and recovery time (45.4%). Routine practice was biopsy without ultrasound in 53.2%, ultrasound marking by a radiologist or technician at the time of biopsy in 24.0%, previous ultrasound marking in 17.7%, and ultrasound marking by the gastroenterologist in 5.1%. For patients with hepatitis C, 76.8% of clinicians perform routine biopsies before treatment.
CONCLUSIONS: A significant proportion of clinicians do not perform liver biopsies; common reasons include the risks of the procedure and the low reimbursement. The use of ultrasound with liver biopsy has become more common. New approaches, especially in training programs, may be necessary to make clinicians more comfortable with this procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12080233     DOI: 10.1097/00004836-200207000-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Trends in the indication and method of liver biopsy for hepatitis B and C.

Authors:  Michael J Lipp; Lionel S D'Souza; David J Clain; Henry C Bodenheimer; Albert D Min
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

2.  Percutaneous liver biopsy practice patterns among Canadian hepatologists.

Authors:  Mohammed Aljawad; Eric M Yoshida; Julia Uhanova; Paul Marotta; Natasha Chandok
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

3.  Percutaneous Liver Biopsy.

Authors:  Maya Gambarin-Gelwan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

4.  Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Authors:  Giada Sebastiani; Peter Ghali; Phil Wong; Marina B Klein; Marc Deschenes; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2014-01

5.  The safety of same-day endoscopy and percutaneous liver biopsy.

Authors:  Jonathan G Stine; Gordon Liss; James H Lewis
Journal:  Dig Dis Sci       Date:  2010-09-21       Impact factor: 3.199

Review 6.  Controversies in liver biopsy: who, where, when, how, why?

Authors:  Lawrence S Friedman
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 7.  Chronic hepatitis C and liver fibrosis.

Authors:  Giada Sebastiani; Konstantinos Gkouvatsos; Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 8.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.

Authors:  Ángel Hernández-Bartolomé; Rosario López-Rodríguez; María Jesús Borque; Leticia González-Moreno; Yolanda Real-Martínez; Luisa García-Buey; Ricardo Moreno-Otero; Paloma Sanz-Cameno
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.